Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Search Icon
Search Icon
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Maternal & Public Health

Fact Sheet: Pro-Life Pregnancy Centers Deliver Real-World Results

 

  • In 2019, pro-life pregnancy centers:
    • Served roughly two million women, men, and youth,
    • Provided services and support valued at nearly $270 million at little to no cost to clients, and
    • Tangible support included medical care and referrals, education, mentoring, and material support including diapers, car seats, and clothing.
  • From 2016 through 2020, pro-life pregnancy centers partnered with pregnant women at-risk for abortion to save over 800,000 lives.
  • Approximately 75% of women at-risk for abortion who view an ultrasound of their baby at a pregnancy center ultimately make the choice to continue their pregnancy.

Latest Posts

October 6, 2026 A magnifying glass rests on three wooden blocks that spell out FDA, symbolizing a review of the REMS modification. A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review October 6, 2026 Ultrasound image showing the side profile of a human baby Inside The Government Decision That Opened Up Abortion Pill Floodgates October 6, 2026 A sign for the FDA featuring the agency’s logo and circular seals in front of a brick government building, where clinical guidance for mifepristone REMS is often determined. Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone

You Might Also Be Interested In

Abortion Reporting: Kentucky (2025)

October 5, 2026
Please login to bookmark Close

Abortion Reporting: Alabama (2025)

October 5, 2026
Please login to bookmark Close

Abortion Reporting: Virginia (2024)

October 5, 2026
Please login to bookmark Close

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image